Searching for your content...
Phone
877-269-7890 from 8 AM - 10 PM ET
Contact Cision
Endo International plc (NASDAQ: ENDP) (TSX: ENL), announced today the completion of the acquisition of rights to Natesto™ (testosterone nasal gel), the first and only testosterone nasal gel for...
Endo International plc (NASDAQ: ENDP) (TSX: ENL), announced today the acquisition of rights to Natesto™ (testosterone nasal gel), the first and only testosterone nasal gel for replacement therapy in...
Natesto™ is the first nasal testosterone replacement therapy approved by FDA TORONTO, May 28, 2014 /CNW/ - Trimel Pharmaceuticals Corporation (TSX: TRL) announced today that the United States Food...
Women treated with Tefina™ 0.6 mg reported a statistically significant increase in orgasms versus placebo TORONTO, May 28, 2014 /CNW/ - Trimel Pharmaceuticals Corporation (TSX: TRL) announced today...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.